Aspect Enters ICU With BIS Anesthesia Monitor Technology: $675 Mil. Market
This article was originally published in The Gray Sheet
Executive Summary
Aspect Medical Systems intends to expand into the $300-$350 mil. market for emergency room and interventional radiology applications with the BIS XP Bispectral Index anesthesia monitoring technology platform within nine to 15 months, the firm says
You may also be interested in...
Aspect Medical Applies EEG Tech To Clinical Depression, Drug Research
The neuroscience division of Aspect Medical Systems expects late 2004 results of a Massachusetts General Hospital (MGH) trial studying the firm's quantitative EEG-based technology as a correlate of depression treatment outcomes will help support a clinical management indication
Aspect Medical Applies EEG Tech To Clinical Depression, Drug Research
The neuroscience division of Aspect Medical Systems expects late 2004 results of a Massachusetts General Hospital (MGH) trial studying the firm's quantitative EEG-based technology as a correlate of depression treatment outcomes will help support a clinical management indication
Boston Scientific/Aspect Medical
Boston Scientific makes $10 mil. equity investment in Aspect and is providing an additional $5 mil. credit facility to support development of Aspect's Bispectral Index (BIS) anesthetic effect/brain monitoring technology for use in gastrointestinal endoscopy, interventional cardiology and radiology suites. The BIS is currently available in intensive care units and operating rooms (11"The Gray Sheet" Feb. 4, 2002, p. 18). In return, Aspect has granted Boston Scientific an option for worldwide distribution rights for the specialty procedures market, as well as an option to purchase up to an aggregate of 25% of Aspect's voting securities in the open market...